Federal contract award
75A50120C00177
TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AZ13 — OTHER RESEARCH AND DEVELOPMENT - ADVANCED DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST SHARING |
| Obligations | $99.1M |
| Current contract value | $99.1M |
| Potential contract value / ceiling | $134.1M |
| Start date | Sep 28, 2020 |
| Current end date | Aug 31, 2027 |
| Potential end date | Dec 31, 2031 |
| Latest award activity | Jul 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 19 of 19 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 21, 2026 | P00018 | $0 | TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS- UPDATE KEY PERSONNEL |
| Jun 30, 2026 | P00017 | $20.0M | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Apr 2, 2026 | P00016 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Dec 3, 2025 | P00015 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Sep 23, 2025 | P00014 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| May 16, 2025 | P00013 | $12.5M | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Feb 18, 2025 | P00012 | $5.5M | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Jul 17, 2024 | P00011 | $10.0M | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Apr 26, 2024 | P00010 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Feb 14, 2024 | P00009 | $15.0M | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Apr 7, 2023 | P00008 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Feb 27, 2023 | P00007 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Sep 13, 2022 | P00006 | $5.0M | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| May 26, 2022 | P00005 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Nov 10, 2021 | P00004 | $0 | EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Sep 30, 2021 | P00003 | $23.8M | TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Jul 23, 2021 | P00002 | $0 | TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Dec 15, 2020 | P00001 | $0 | TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
| Sep 25, 2020 | 0 | $7.4M | TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. |
Estimated positioning window
Dec 31, 2030 – Jun 30, 2031
Recompete signal: . Rule-based research score; positioning dates are estimates.
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2031-12-31 (1893 days from calculation)
- +5 points
- 2 historical awards in this buyer and category group
- +10 points
- 19 recorded award transactions
- +10 points
- Latest award action: 2026-07-21
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.